Accurate and reliable detection of SARS-CoV-2 is critical
for the
effective prevention and rapid containment of COVID-19. Current approaches
suffer from complex procedures or a single signal readout, resulting
in an increased risk of false negatives and low sensitivity. Here,
we developed a fluorescence (FL) and electrochemiluminescence (ECL)
dual-mode imaging platform based on a self-powered DNAzyme walker
to achieve accurate surveillance of SARS-CoV-2 spike protein at the
single-molecule level. The specific activation of the DNAzyme walker
by the target protein provides the power for the system’s continuous
running, enabling the simultaneous recording of the reduction in fluorescence
spots and the appearance of ECL spots generated by the Ru-doped metal–organic
framework (MOF) emitter. Therefore, the constructed imaging platform
can achieve dual-mode detection of spike protein via reverse dual-signal
feedback, which could effectively eliminate false-positive or false-negative
signals and improve the detection accuracy and sensitivity with a
low detection limit. In particular, the dual-mode accuracy of spike
protein diagnosis in samples has been significantly improved compared
to single-signal output means. In addition, this dual-mode imaging
platform may become a prospective diagnostic device for other infectious
viruses